Related Experiment Videos

Analogues of atriopeptin(103-125)amide having high binding selectivity

K L Spear1, M S Brown, G M Olins

  • 1Cardiovascular Diseases Research Department, Searle Research and Development Division, G. D. Searle and Company, Chesterfield, Missouri 63198.

Summary

Researchers modified atrial peptides, finding that changes to their structure affect binding to vasorelaxant (VR) receptors but not nonvasorelaxant (NVR) binding sites. This suggests VR receptors require specific ligand structures.

Related Concept Videos